Trial Profile
Postconditioning used for the limitation of infarct size in patients with ST-elevation myocardial infarction (POSTCON).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms POSTCON
- 06 Dec 2016 New trial record